Cancer stages describe how much cancer is in your body and how far it has spread from where it started. They range from Stage 0 (abnormal cells that haven’t invaded surrounding tissue) to Stage IV (cancer that has spread to distant organs). The stage assigned at diagnosis is one of the most important factors in determining treatment options and outlook.
How Staging Works: The TNM System
Most cancers are staged using a system called TNM, which evaluates three things. T describes the size of the primary tumor and whether it has grown into nearby tissue. N describes whether cancer has reached nearby lymph nodes, and if so, how many. M describes metastasis, meaning whether cancer has spread to distant parts of the body. Each letter gets a number: a T1 tumor is small and contained, while a T4 tumor is large or has grown deeply into surrounding structures. N0 means no lymph nodes are involved; N3 means cancer is found in many nearby nodes.
Doctors combine these three values to assign an overall stage from 0 to IV. Two people with the same cancer type can receive different stages based on their unique combination of tumor size, node involvement, and metastasis.
Stage 0: Abnormal Cells That Haven’t Spread
Stage 0, also called carcinoma in situ, means abnormal cells that look like cancer under a microscope are present but confined to the exact spot where they first formed. They haven’t pushed into surrounding tissue. Common examples include ductal carcinoma in situ in the breast, squamous cell carcinoma in situ in the skin, and adenocarcinoma in situ in the lungs or cervix.
Stage 0 is not technically invasive cancer. These cells may eventually become cancerous and spread into normal tissue, which is why they’re typically removed or treated early. The prognosis at this stage is excellent.
Stages I, II, and III: Cancer That’s Still Regional
These three stages all mean cancer is confirmed, but it hasn’t traveled to distant organs. The higher the number, the larger the tumor and the more it has spread into nearby tissues or lymph nodes.
Stage I generally means a small tumor that remains in the organ where it started, with no lymph node involvement. Stage II typically indicates a larger tumor, or one that has begun to reach a small number of nearby lymph nodes. Stage III usually means the cancer is larger still, has grown into nearby structures, or has spread to several regional lymph nodes. The exact size and node thresholds vary by cancer type. A Stage II breast cancer and a Stage II colon cancer don’t necessarily look the same, but the principle is identical: more spread equals a higher number.
The distinction between these stages matters because it changes how treatment is approached. Early-stage cancers (Stages I and II) are more likely to be treated with localized therapies focused on removing or destroying the tumor in that specific location. Stage III cancers often require a combination of local and body-wide treatments, since cancer cells may have started migrating beyond the primary site.
Stage IV: Cancer That Has Spread to Distant Organs
Stage IV means cancer has metastasized, spreading from its original location to distant organs or tissues. A breast cancer that has traveled to the bones or lungs, for example, would be classified as Stage IV. The cancer cells in those distant sites are still breast cancer cells, not bone or lung cancer, which is why it’s called metastatic breast cancer rather than a new cancer type.
The survival gap between early and late stages can be dramatic. For lung cancer, 61% of people diagnosed at an early stage live at least five years. For those diagnosed at Stage IV, that number drops to 7%. These statistics vary enormously by cancer type, and individual outcomes depend on many factors, but the pattern holds: earlier detection generally means better outcomes.
Treatment at Stage IV typically shifts in focus. Rather than aiming to eliminate the cancer entirely, the goal often becomes slowing its spread, shrinking tumors, and relieving symptoms. These treatments travel through the bloodstream to reach cancer cells throughout the body.
How Doctors Determine Your Stage
Staging relies on a combination of imaging tests and tissue analysis. CT scans use X-rays taken from multiple angles to create detailed 3D images of your organs, sometimes with a contrast dye swallowed or injected to make certain areas easier to see. PET scans work differently: you receive an injection of radioactive glucose, and because cancer cells tend to absorb more glucose than healthy cells, they light up on the scan. This helps pinpoint where cancer exists in the body.
A biopsy, where a small sample of tissue is removed and examined under a microscope, confirms whether cells are cancerous. In some cases, a sentinel lymph node biopsy checks whether cancer has reached the first lymph node it would drain into, helping determine the N component of the TNM score. Your doctor may order several of these tests to build a complete picture before assigning a stage.
You may see your stage described as “clinical” or “pathological.” A clinical stage is based on imaging and physical exams done before surgery. A pathological stage comes after surgery, when a pathologist examines the removed tissue directly. The pathological stage is generally more precise, and it can sometimes differ from the initial clinical estimate.
Grade vs. Stage: Two Different Measurements
Stage and grade are often confused, but they measure different things. Stage describes how far cancer has spread through the body. Grade describes how abnormal the cancer cells themselves look under a microscope, which reflects how aggressively they’re likely to behave.
Pathologists determine grade by examining three things: how much the tumor cells resemble normal tissue, how abnormal the cell nuclei appear, and how quickly the cells are dividing. Low-grade cancers tend to grow slowly and look relatively normal. High-grade cancers divide rapidly and look very different from healthy cells.
Both factors influence your outlook. Low-stage cancers (Stages 0 through II) tend to have better long-term outcomes than high-stage cancers (Stages III and IV), and low-grade cancers tend to be less aggressive than high-grade ones. A small, low-grade tumor carries a very different prognosis than a small, high-grade one, which is why doctors consider both measurements together. For breast cancer specifically, the staging system now formally incorporates grade along with hormone receptor status and genetic test results into what’s called a prognostic stage group, giving a more complete picture than tumor size alone.
Why Your Stage Number Doesn’t Change
One detail that surprises many people: your cancer stage is assigned at diagnosis and stays the same, even if the cancer later grows or shrinks. If a Stage II colon cancer returns after treatment and spreads to the liver, it’s described as “Stage II colon cancer, now metastatic” rather than being re-staged as Stage IV. This convention exists so that doctors and researchers can compare outcomes accurately over time. Your treatment plan, however, will always reflect the current state of the disease, regardless of the original stage label.